SG Americas Securities
NVAX icon

SG Americas Securities’s Novavax NVAX Stock Holding History

SG Americas Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-143,100
Closed -$64K – 3170
2024
Q1 		$64K Buy
+143,100
New +$664K ﹤0.01% 2689
2023
Q1 		– Sell
-16,500
Closed -$2.94M – 3461
2022
Q4 		$2.94M Hold
16,500
– – 0.04% 418
2022
Q3 		$2.8M Hold
16,500
– – 0.03% 440
2022
Q2 		$2.3M Hold
16,500
– – 0.02% 663
2022
Q1 		$1.96M Sell
16,500
-100,000
-86% -$8.92M 0.01% 927
2021
Q4 		$4.77M Buy
116,500
+104,500
+871% +$18M 0.03% 522
2021
Q3 		$587K Hold
12,000
– – ﹤0.01% 2354
2021
Q2 		$672K Buy
+12,000
New +$2.2M ﹤0.01% 1794

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG Americas Securities's NVAX Position: Q1 2026 in Review

SG Americas Securities reduced its Novavax (NVAX) stake by 86% in Q1 2026, selling an estimated $7.57M and leaving 141,085 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1676.

SG Americas Securities first reported a position in NVAX in Q2 2013 and has held it in 49 quarters since. The position peaked at $14.6M in Q3 2024. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • SG Americas Securities held 141,085 shares of Novavax worth $1.15M as of Q1 2026.
  • SG Americas Securities sold 835,303 Novavax shares in Q1 2026, an estimated $7.57M.
  • Novavax made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1676 holding.
  • SG Americas Securities first reported a position in Novavax in Q2 2013 and has held it in 49 quarters since.
  • SG Americas Securities's Novavax position peaked at $14.6M in Q3 2024.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.